Steroid sulfatase inhibitors: A review covering the promising 2000-2010 decade

Steroids

Volumn 76, Issue 10-11, 2011, Pages 929-948

  Maltais, René ^a   Poirier, Donald ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Enzyme; Hormone; Inhibitor; Sulfamate; Sulfatase

Indexed keywords

16 BETA AMINOPROPYL E2; 17 ALPHA PIPERAZINOMETHYL E2; 2 (METHOXY/ETHYL)E2 3 O SULFAMATE; 2 HALOGENATED E1 3 O SULFAMATE; 2 METHOXY 3 SULFAMOYLOXY 17 ALPHA BENZYL; 2',3' OXATHIAZINE; 3 SULFAMATE 16,17 SECO ESTRA 1,3,5 (10)TRIENE 16,17 IMIDE; 3,17 O DISULFAMATE; ANTINEOPLASTIC AGENT; BENZOMATE; CEREBROSIDE SULFATASE; DISULFAMATE ISOFLAVONE; E1 3 O SULFAMATE; ESTERASE INHIBITOR; ESTRATRIENE 17 O SULFAMATE; ESTRATRIENE 3 O SULFAMATE; IROSUSTAT; KW 2581; LETROZOLE; N ACETYLGALACTOSAMINE 4 SULFATASE; RHO TERT BUTYLBENZYL 1,3,5 (10)ESTRATRIEN 17 BETA OL; SR 16137; SR 16157; STEROID SULFATASE INHIBITOR; STERYL SULFATASE; STX 1938; STX 213; STX 681; TZS 8478; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE; ADDITION REACTION; ALOPECIA; ANTINEOPLASTIC ACTIVITY; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CATALYSIS; CELL PROLIFERATION; CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; ELIMINATION REACTION; ENDOMETRIUM CANCER; ENDOPLASMIC RETICULUM; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME STRUCTURE; HIRSUTISM; HUMAN; INHIBITION KINETICS; LIPOPHILICITY; NONHUMAN; OVARY CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PLACENTA; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN HYDROLYSIS; PSORIASIS; REVIEW; SINGLE DRUG DOSE; SOLID PHASE SYNTHESIS; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; TRANSESTERIFICATION;

ENZYME INHIBITORS; MOLECULAR STRUCTURE; STERYL-SULFATASE; SULFONIC ACIDS;

EID: 79960473403     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.03.010     Document Type: Review

References (150)

1. A.H. Payne, and D.B. Hales Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones Endocr Rev 25 2004 947 970 (Pubitemid 39657774)
2. P.S. Herson, I.P. Koerner, and P.D. Hurn Sex, sex steroids, and brain injury Seminars in reproductive medicine 2009 Thieme New York, NY pp. 229-39
3. N.M. Hamilton Therapeutic potential of steroids for CNS disorders Expert Opin Ther Patents 11 2001 1523 1531 (Pubitemid 33019603)
4. E. von Angerer The estrogen receptor as a target for rational drug design Molecular biology intelligence unit 1995 R.G. Landes Company Austin, TX
5. C.J. Bagatell, and W.J. Bremner Androgens in health and disease 2003 Humana Press Totowa, NJ
6. J.B. Pippal, and P.J. Fuller Structure-function relationships in the mineralocorticoid receptor J Mol Endocrinol 41 2008 405 413
7. R. Maltais, M.R. Tremblay, L.C. Ciobanu, and D. Poirier Steroids and combinatorial chemistry J Comb Chem 6 2004 443 456 (Pubitemid 39091263)
8. E. Milgrom Steroid hormones E.E. Baulieu, P.A. Kelly, Hormones: from molecules to disease 1990 Hermann, Publishers in Arts and Science Paris 385 437
9. V. Luu-The, and F. Labrie The intracrine sex steroid biosynthesis pathways L. Martini, Progress in brain research 181 2010 Elsevier 177 192 [chapter 10]
10. J.T. Sanderson The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals Toxicol Sci 94 2006 3 21 (Pubitemid 44542325)
11. K. Kulig, and B. Malawska Trends in the development of new drugs for treatment of benign prostatic hyperplasia Curr Med Chem 13 2006 3395 3416 (Pubitemid 44873752)
12. S.V. Frye Discovery and clinical development of dutasteride, a potent dual 5α-reductase inhibitor Curr Top Med Chem 6 2006 405 421
13. B. Djavan, S. Milani, and Y.K. Fong Dutasteride: a novel dual inhibitor of 5alpha-reductase for benign prostatic hyperplasia Expert Opin Pharm 6 2005 311 317 (Pubitemid 40305342)
14. J. McConnell, and E. Stoner 5α-reductase inhibitors Adv Protein Chem 56 2001 143 180
15. B. Kenny, S. Ballard, J. Blagg, and D. Fox Pharmacological options in the treatment of benign prostatic hyperplasia J Med Chem 40 1997 1293 1315 (Pubitemid 27198078)
16. J.J. Li Aromatase inhibitors for breast cancer: exemestane (Aromasin) anastrazole (Arimidex) and letrozole (Femara) D.S. Johnson, J.J. Li, The art of drug synthesis 2007 Wiley 31 88
17. R.W. Brueggemeier, J.C. Hackett, and E.S. Diaz-Cruz Aromatase inhibitors in the treatment of breast cancer Endocr Rev 26 2005 331 345 (Pubitemid 40686647)
18. I.E. Smith, and M. Dowsett Aromatase inhibitors in breast cancer N Engl J Med 348 2003 2431 2442 (Pubitemid 36682823)
19. A.M. Brodie, and V.C. Njar Aromatase inhibitors and their application in breast cancer treatment Steroids 65 2000 171 179 (Pubitemid 30129250)
20. R.J. Santen, and H.A. Harvey Use of aromatase inhibitors in breast carcinoma Endocr Relat Cancer 6 1999 75 92 (Pubitemid 29197232)
21. D. Poirier New cancer drugs targeting the biosynthesis of estrogens and androgens Drug Dev Res 69 2008 304 318
22. S.R. Hanson, M.D. Best, C.H. Wong, and Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility Angew Chem Int Ed Engl 43 2004 5736 5763 (Pubitemid 39532028)
23. R. Hobkirk Steroid sulfation current concept TEM 4 1993 69 74
24. P. Nussbaumer, and A. Billich Steroid sulfatase inhibitors Expert Opin Ther Patents 13 2003 605 625 (Pubitemid 36622215)
25. M.J. Reed, A. Purohit, L.W. Woo, S.P. Newman, and B.V.L. Potter Steroid sulfatase: molecular biology, regulation, and inhibition Endocr Rev 26 2005 171 202
26. D. Ghosh Human sulfatases: a structural perspective to catalysis Cell Mol Life Sci 64 2007 2013 2022 (Pubitemid 47094434)
27. F.G. Hernandez-Guzman, T. Higashiyama, W. Pangborn, Y. Osawa, and D. Ghosh Structure of human estrone sulfatase suggests functional roles of membrane association J Biol Chem 278 2003 22989 22997 (Pubitemid 36830364)
28. P. Bojarova, E. Denehy, I. Walker, K. Loft, D.P. De Souza, and L.W.L. Woo Direct evidence for ArO-S bond cleavage upon inactivation of Pseudomonas aeruginosa arylsulfatase by aryl sulfamates ChemBioChem 9 2008 613 623
29. A. Subramanian, M. Salhab, and K. Mokbel Oestrogen producing enzymes and mammary carcinogenesis: a review Breast Cancer Res Treat 111 2008 191 202
30. M.J. Reed, and A. Purohit Sulphatase inhibitors: the rationale for the development of a new endocrine therapy Endocr Relat Cancer 45 1933 51 62
31. M.J. Reed, and A. Purohit M. Sanders, J. Smith, Design of enzyme inhibitors as drugs, vol. 2 1994 Oxford University Press Oxford 481 494
32. M.J. Reed, A. Purohit, N.M. Howarth, and B.V.L. Potter Steroid sulphatase inhibitors: a new endocrine therapy Drugs Future 19 1994 673 680 (Pubitemid 24261331)
33. M.J. Reed, A. Purohit, L.W.L. Woo, and B.V.L. Potter The development of steroid sulphatase inhibitors Endocr Relat Cancer 3 1996 9 23 (Pubitemid 26153377)
34. N.M. Howarth, A. Purohit, and M.J. Reed Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential J Med Chem 37 1994 219 221 (Pubitemid 24063038)
35. D. Poirier, L.C. Ciobanu, and R. Maltais Steroid sulfatase inhibitors Expert Opin Ther Patents 9 1999 1083 1099 (Pubitemid 29380979)
36. H.J. Smith, P.J. Nicholls, C. Simons, and R. Le Lain Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers Expert Opin Ther Patents 11 2001 789 824 (Pubitemid 32427704)
37. S. Ahmed, C.P. Owen, K. James, L. Sampson, and C.K. Patel Review of estrone sulfatase and its inhibitors-an important new target against hormone dependent breast cancer Curr Med Chem 9 2002 263 273 (Pubitemid 34436444)
38. P. Nussbaumer, and A. Billich Steroid sulfatase inhibitors Med Res Rev 24 2004 529 576 (Pubitemid 38802700)
39. A. Horvath, and A. Billich Steroid sulphatase inhibitors Expert Opin Ther Patents 15 2005 1541 1553
40. L.W.L. Woo Enzyme inhibitor examples for the treatment of breast cancer. Enzymes and their inhibition Drug Develop 2005 221 241
41. P.A. Foster, M.J. Reed, and A. Purohit Recent developments of steroid sulfatase inhibitors as anti-cancer agents Anti-Cancer Agents Med Chem 8 2008 732 738
42. K. Aidoo-Gyamfi, T. Cartledge, K. Shah, and S. Ahmed Estrone sulfatase and its inhibitors Anti-Cancer Agents Med Chem 9 2009 599 612
43. Li PK, Akinaga S, Murakata C. Steroid sulfatase inhibitors and methods for making and using the same. PCT Int Appl WO 2000043408; 2000.
44. Li PK, Murakata C, Akinaga S. Steroid sulfatase inhibitors and methods for making and using the same. US patent 6288050; 2001.
45. Li PK, Murakata C, Akinaga S. Steroid sulfatase inhibitors and methods for making and using the same. US patent 6376687; 2002.
46. H. Ishida, T. Nakata, M. Suzuki, Y. Shiotsu, H. Tanaka, and N. Sato A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models Breast Cancer Res Treat 106 2007 215 217
47. H. Ishida, T. Nakata, N. Sato, P.K. Li, T. Kuwabara, and S. Akinaga Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo Breast Cancer Res Treat 104 2007 211 219 (Pubitemid 47084225)
48. Schwarz S, Kosemund D, Müller G, Richter M, Peters O, Droescher P, et al. Ent-steroids as selectively effective estrogens. PCT Int Appl WO 2000/063228; 2000.
49. 13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds. US patent 6583130; 2003.
50. D. Poirier, and R.P. Boivin 17 alpha-alkyl- or 17 alpha-substituted benzyl-17 beta-estradiols: a new family of estrone-sulfatase inhibitors Bioorg Med Chem Lett 8 1998 1891 1896 (Pubitemid 28338012)
51. L.C. Ciobanu, R.P. Boivin, V. Luu-The, F. Labrie, and D. Poirier Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17α-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and C17α of estradiol J Med Chem 42 1999 2280 2286 (Pubitemid 29284249)
52. Jinbo Y, Inoue Y. Novel estradiol derivatives. PCT Int Appl WO 2000053620; 2000.
53. Reed MJ, Potter BVL, Hejaz H, Purohit A. Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase. PCT Int Appl WO 2001044268; 2001.
54. J.E. Reed, L.W.L. Woo, J.J. Robinson, B. Leblond, M.P. Leese, A. Purohit, M.J. Reed, and B.V.L. Potter 2-Difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor Biochem Biophys Res Commun 317 2004 169 175 (Pubitemid 38401979)
55. Potter BVL, Reed MJ. Thioether-sulfamate steroids as steroid sulfatase inhibitors and anti-cancer compounds. PCT Int Appl WO 2002016394; 2002.
56. M.P. Leese, B. Leblond, S.P. Newman, A. Purohit, M.J. Reed, and B.V.L. Potter Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates J Steroid Biochem Mol Biol 94 2005 239 251 (Pubitemid 40614537)
57. Potter BVL, Reed MJ. Oestrogen-17-sulfamates as inhibitors of steroid sulfatase. PCT Int. Appl. WO 2002016392; 2002
58. C. Bubert, M.P. Leese, M.F. Mahon, E. Ferrandis, S. Regis-Lydi, and P.G. Kasprzyk 3,17-Disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity J Med Chem 50 2007 4431 4443 (Pubitemid 47378840)
59. M.P. Leese, B. Leblond, A. Smith, S.P. Newman, A. Di Fiore, and G. De Simone 2-Substituted estradiol bis-sulfamates, multitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography, and in vivo activity J Med Chem 49 2006 7683 7696 (Pubitemid 46033660)
60. M.P. Leese, F.L. Jourdan, K. Gaukroger, M.F. Mahon, S.P. Newman, and P.A. Foster Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents J Med Chem 51 2008 1295 1308 (Pubitemid 351480390)
61. F. Jourdan, C. Bubert, M.P. Leese, A. Smith, E. Ferrandis, and S. Regis-Lydi Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modeling Org Biomol Chem 6 2008 4108 4119
62. D.S. Fischer, L.W.L. Woo, M.F. Mahon, A. Purohit, M.J. Reed, and B.V.L. Potter D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase Bioorg Med Chem 11 2003 1685 1700 (Pubitemid 36349150)
63. D.S. Fischer, S.K. Chander, L.W.L. Woo, J.C. Fenton, A. Purohit, M.J. Reed, and B.V.L. Potter Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity J Steroid Biochem Mol Biol 84 2003 343 349 (Pubitemid 36514849)
64. P.A. Foster, S.P. Newman, S.K. Chander, C. Stengel, R. Jhalli, and L.W.L. Woo In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy Clin Cancer Res 12 2006 5543 5549 (Pubitemid 44497272)
65. L.W.L. Woo, D.S. Fischer, C.M. Sharland, M. Trusselle, P.A. Foster, and S.K. Chander Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography Mol Cancer Ther 7 2008 2435 2444
66. D. Poirier, L.C. Ciobanu, and M. Berube A multidetachable sulfamate linker successfully used in a solid-phase strategy to generate libraries of sulfamate and phenol derivatives Bioorg Med Chem Lett 12 2002 2833 2838 (Pubitemid 35266744)
67. L.C. Ciobanu, and D. Poirier Synthesis of libraries of 16β-aminopropyl estradiol derivatives for targeting two key steroidogenic enzymes Chem Med Chem 1 2006 1249 1259 (Pubitemid 44786931)
68. L.C. Ciobanu, and D. Poirier Solid-phase parallel synthesis of 17α-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker J Comb Chem 5 2003 429 440 (Pubitemid 37140554)
69. L.C. Ciobanu, V. Luu-The, C. Martel, F. Labrie, and D. Poirier Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase Cancer Res 63 2003 6442 6446 (Pubitemid 37255194)
70. L.C. Ciobanu, R.P. Boivin, V. Luu-The, and D. Poirier 3β-Sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors J Enzyme Inhib Med Chem 18 2003 15 26 (Pubitemid 36221710)
71. R.H. Peters, W.R. Chao, B. Sato, K. Shigeno, N.T. Zaveri, and M. Tanabe Steroidal oxathiazine inhibitors of estrone sulfatase Steroids 68 2003 97 110 (Pubitemid 35418307)
72. Y. Liu, V. Ahmed, B. Hill, and S.D. Taylor Synthesis of a non-hydrolyzable estrone sulfate analogue bearing the difluoromethanesulfonamide group and its evaluation as a steroid sulfatase inhibitor Org Biomol Chem 3 2005 3329 3335 (Pubitemid 41423968)
73. Messinger J, Thole HH, Husen B, Weske M, Koskimies P, Pirkkala L. 17β-HSD1 and STS inhibitors. US patent 2006281710; 2006.
74. M. Numazawa, T. Tominaga, Y. Watari, and Y. Tada Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates Steroids 71 2006 371 379
75. L.M. Rasmussen, N.T. Zaveri, J. Stenvang, R.H. Peters, and A.E. Lykkesfeldt A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer Breast Cancer Res Treat 106 2007 191 203 (Pubitemid 350045017)
76. Reed MJ, Potter BVL. Compound. US patent 6921776; 2005.
77. L.W.L. Woo, A. Purohit, B. Malini, M.J. Reed, and B.V.L. Potter Potent active site-directed inhibition of steroid sulfatase by tricyclic coumarin-based sulfamates Chem Biol 7 2000 773 791
78. B. Malini, A. Purohit, D. Ganeshapillai, L.W.L. Woo, B.V.L. Potter, and M.J. Reed Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates J Steroid Biochem Mol Biol 75 2000 253 258 (Pubitemid 32244254)
79. A. Purohit, L.W.L. Woo, B.V.L. Potter, and M.J. Reed In vivo inhibition of estrone sulfatase activity and growth of nitromethylurea-induced mammary tumors by 667 COUMATE Cancer Res 60 2000 3394 3396 (Pubitemid 30482153)
80. S.J. Stanway, A. Purohit, L.W.L. Woo, S. Sufi, D. Vigushin, and R. Ward Phase I, study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor Clin Cancer Res 12 2006 1585 1592
81. S.J. Stanway, P. Delavault, A. Purohit, L.W.L. Woo, C. Thurieau, and B.V.L. Potter Steroid sulfatase: a new target for the endocrine therapy of breast cancer The Oncologist 12 2007 370 374 (Pubitemid 46698714)
82. Reed MJ, Potter BVL. Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using. US patent 6506792; 2003.
83. H.A.M. Hejaz, L.W.L. Woo, A. Purohit, M.J. Reed, and B.V.L. Potter Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase Bioorg Med Chem 12 2004 2759 2772 (Pubitemid 38542799)
84. L.W.L. Woo, C. Bubert, O.B. Sutcliffe, A. Smith, S.K. Chander, and M.F. Mahon Dual aromatase-steroid sulfatase inhibitors J Med Chem 50 2007 3540 3560 (Pubitemid 47195462)
85. C. Bubert, L.W.L. Woo, O.B. Sutcliffe, M.F. Mahon, S.K. Chander, and A. Purohit Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino) benzonitrile: SAR, crystal structures, in vitro and in vivo activities ChemMedChem 3 2008 1708 1730
86. Potter BVL, Reed MJ, Woo LWL, Purohit A, Burbert C, Wood P, et al. Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activity. US patent 2007213383; 2007.
87. P.M. Wood, L.W.L. Woo, J.R. Labrosse, M.N. Trusselle, S. Abbate, and G. Longhi Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity J Med Chem 51 2008 4226 4238 (Pubitemid 352032447)
88. L.W.L. Woo, T. Jackson, A. Putey, G. Cozier, P. Leonard, and K. Acharya Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template J Med Chem 53 2010 2155 2170
89. S. Ahmed, K. James, C.P. Owen, C.K. Patel, and M. Patel Novel inhibitors of the enzyme estrone sulfatase (ES) Bioorg Med Chem Lett 11 2001 841 844 (Pubitemid 32230693)
90. S. Ahmed, K. James, and C.P. Owen Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid Bioorg Med Chem Lett 12 2002 2391 2394 (Pubitemid 34879873)
91. C. Owen, K. James, L. Sampson, and S. Ahmed Synthesis and biochemical evaluation of some novel benzoic acid based esters as potential inhibitors of oestrone sulphatase J Pharm Pharmacol 55 2002 85 93
92. C.P. Owen, C.K. Patel, T. Cartledge, and S. Ahmed Synthesis and in vitro biochemical evaluation of a series of cycloalkyl esters of 4-sulfamoylated benzoic acid as inhibitors of estrone sulfatase (ES) Lett Drug Design Discov 4 2007 399 403 (Pubitemid 47607749)
93. C.K. Patel, C.P. Owen, and S. Ahmed Inhibition of estrone sulfatase (ES) by alkyl and cycloalkyl ester derivatives of 4-[(aminosulfonyl)oxy] benzoic acid Bioorg Med Chem Lett 14 2004 605 609 (Pubitemid 38114836)
94. C.P. Owen, M. Patel, C.K. Patel, T. Cartledge, and S. Ahmed Synthesis and in vitro biochemical evaluation of a series of compounds as potential inhibitors of estrone sulfatase (ES) and the role of pKa in both the synthesis and the inhibitory activity of the potential inhibitors Lett Drug Des Discov 4 2007 394 398 (Pubitemid 47607748)
95. S. Ahmed, K. James, C.P. Owen, and C.K. Patel Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES) Bioorg Med Chem Lett 12 2002 1343 1346 (Pubitemid 34454809)
96. S. Ahmed, K. James, and C.P. Owen The design, synthesis, and biochemical evaluation of derivatives of biphenyl sulfamate-based compounds as novel inhibitors of estrone sulfatase Biochem Biophys Res Commun 294 2002 180 183 (Pubitemid 34687234)
97. S. Ahmed, K. James, and C.P. Owen Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES) J Steroid Biochem Mol Biol 82 2002 425 435 (Pubitemid 36183195)
98. Koizumi N, Okada M, Iwashita S, Takegawa S, Nakagawa T, Takahashi H, et al. Phenyl sulfamate derivatives. PCT Int Appl WO 2001002349; 2001.
99. M. Okada, T. Nakagawa, S. Iwashita, S. Takegawa, T. Fujii, and N. Koizumi Development of novel steroid sulfatase inhibitors I, synthesis and biological evaluation of biphenyl-4-O-sulfamates J Steroid Biochem Mol Biol 87 2004 141 148
100. T. Saito, S. Kinoshita, T. Fujii, K. Bandoh, S. Fuse, and Y. Yamauchi Development of novel steroid sulfatase inhibitors II, TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats J Steroid Biochem Mol Biol 88 2004 167 173 (Pubitemid 38482033)
101. Takegawa S, Iwashita S, Okada M, Nakagawa T, Koizumi N, Fujii T. Cyclic aminophenyl sulfamate derivative. PCT Int Appl WO 2004103971; 2004.
102. Billich A, Schreiner EP, Wolff-Winiski B, Benzoxa- and benzthiazoles. PCT Int Appl WO 2001036398; 2001.
103. E.P. Schreiner, B. Wolff, A.P. Winiski, and A. Billich 6-(2-Adamantan-2-ylidenehydroxybenzoxazole)-O-sulfamate: a potent non-steroidal irreversible inhibitor of human steroid sulfatase Bioorg Med Chem Lett 13 2003 4313 4316 (Pubitemid 37492964)
104. A. Billich, J.G. Meingassner, P. Nussbaumer, S. Desrayaud, C. Lam, and Winiski 6-[2-(Adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases J Steroid Biochem Mol Biol 92 2004 29 37 (Pubitemid 39486060)
105. P. Nussbaumer, P. Lehr, and A. Billich 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase J Med Chem 45 2002 4310 4320 (Pubitemid 35025577)
106. P. Nussbaumer, A.P. Winiski, and A. Billich Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase J Med Chem 46 2003 5091 5094 (Pubitemid 37352047)
107. P. Nussbaumer, M. Bilban, and A. Billich 4,4'-Benzophenone-O,O'- disulfamate: a potent inhibitor of steroid sulfatase Bioorg Med Chem Lett 12 2002 2093 2095 (Pubitemid 34804373)
108. L.C. Ciobanu, V. Luu-The, and D. Poirier Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors J Steroid Biochem Mol Biol 80 2002 339 353 (Pubitemid 34304157)
109. D. Fournier, P.A. Breuil, and D. Poirier Synthesis of aryl sulfamate and phenol small peptide derivatives using a multidetachable sulfamate linker strategy Adv Exp Med Biol 611 2009 219 220
110. T. Golob, R. Liebl, and E. Von Angerer Sulfamoyloxy-substituted 2-phenylindoles, antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells Bioorg Med Chem 10 2002 3941 3953 (Pubitemid 36164693)
111. Ino Y, Amishiro N, Muramatsu K, Shiotsu Y, Murakata C. Aryl sulfamate derivatives. PCT Int Appl WO 2003020690; 2003.
112. Lafay J, Rondot B, Carniato D, Bonnet P, Clerc T, Shields J, et al. Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors. WO 2004101545; 2004.
113. Staehle W, Bruge D, Scholz G, Rondot B, Lafay J. Sulphamate benzothiophenes derivatives. PCT Int Appl WO 2008067892; 2008.
114. R.P. Boivin, V. Luu-The, R. Lachance, F. Labrie, and D. Poirier Structure-activity relationships of 17α-derivatives of estradiol as inhibitors of steroid sulfatase J Med Chem 43 2000 4465 4478 (Pubitemid 32046871)
115. R. Maltais, D. Fournier, and D. Poirier Quantitative structure-activity relationship (QSAR) study with a series of 17α-derivatives of estradiol: model for the development of reversible steroid sulfatase inhibitors QSAR Comb Sci 28 2009 1284 1299
116. L.C. Ciobanu, R.P. Boivin, V. Luu-The, and D. Poirier Synthesis and steroid sulfatase inhibitory activity of C19- and C21-steroidal derivatives bearing a benzyl-inhibiting group Eur J Med Chem 36 2001 659 671 (Pubitemid 32964736)
117. D. Fournier, and D. Poirier Estradiol dimers as a new class of steroid sulfatase reversible inhibitors Bioorg Med Chem Lett 19 2009 693 696
118. E.P. Schreiner, and A. Billich Estrone formate: a novel type of irreversible inhibitor of human steroid sulfatase Bioorg Med Chem Lett 14 2004 4999 5002 (Pubitemid 39165610)
119. J. Lapierre, V. Ahmed, M.J. Chen, M. Ispahany, J.G. Guillemette, and S.D. Taylor The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors Bioorg Med Chem Lett 14 2004 151 155 (Pubitemid 38010211)
120. V. Ahmed, Y. Liu, C. Silvestro, and S.D. Taylor Boronic acids as inhibitors of steroid sulfatase Bioorg Med Chem 14 2006 8564 8573 (Pubitemid 44667532)
121. V. Ahmed, Y. Liu, and S.D. Taylor Multiple pathways for the irreversible inhibition of steroid sulfatase with quinone methide-generating suicide inhibitors ChemBioChem 10 2009 1457 1461
122. Y. Liu, F. Lien, S. Ruttgaizer, P. Dove, and S.D. Taylor Synthesis and protection of aryl sulfates using the 2,2,2-trichloroethyl moiety Org Lett 6 2004 209 212 (Pubitemid 38175752)
123. P. Jutten, W. Schumann, A. Hartl, L. Heinisch, U. Grafe, and W. Werner A novel type of nonsteroidal estrone sulfatase inhibitors Bioorg Med Chem Lett 12 2002 1339 1342 (Pubitemid 34454808)
124. P. Jutten, W. Schumann, A. Hartl, H.M. Dahse, and U. Grafe Thiosemicarbazones of formyl benzoic acids as novel potent inhibitors of estrone sulfatase J Med Chem 50 2007 3661 3666 (Pubitemid 47195471)
125. Lehr P. Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase. PCT Int Appl WO 2003082842; 2003.
126. P. Nussbaumer, D. Geyl, A. Horvath, P. Lehr, B. Wolff, and A. Billich Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase Bioorg Med Chem Lett 13 2003 3673 3677 (Pubitemid 37206484)
127. P. Lehr, A. Billich, B. Wolff, and P. Nussbaumer N-acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase Bioorg Med Chem Lett 15 2005 1235 1238 (Pubitemid 40458680)
128. A. Horvath, P. Nussbaumer, B. Wolff, and A. Billich 2-(1-Adamantyl)-4- (thio)chromenone-6-carboxylic acids: potent reversible inhibitors of human steroid sulfatase J Med Chem 47 2004 4268 4276 (Pubitemid 39045432)
129. Schreiner EP. N-sulfonylaminothiazole. PCT Int Appl WO 2004043968; 2004.
130. A. Preusser-Kunzel, M. Mariappan, B. Schmidt, S.L. Gande, K. Mutenda, and D. Wenzel Molecular characterization of the human Cα-formylglycine- generating enzyme J Biol Chem 280 2005 14900 14910 (Pubitemid 40562840)
131. S.R. Hanson, L.J. Whalen, and C.H. Wong Synthesis and evaluation of general mechanism-based inhibitors of sulfatase based on (difluoro)methyl phenyl sulfate and cyclic phenyl sulfamate motifs Bioorg Med Chem 14 2006 8386 8395 (Pubitemid 44667544)
132. P. Bojarova, and S.J. Williams Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination Curr Opin Chem Biol 12 2008 573 581
133. W.J. Spillane, and J.B. Malaubier Mechanism of the hydrolysis of the sulfamate EMATE-an irreversible steroid sulfatase inhibitor Tetrahedron Lett 51 2010 2059 2062
134. W.J. Spillane, C.J.A. McCaw, and N.P. Maguire Kinetic and mechanistic studies of the hydrolysis of sulfamate esters: a non-elimination decomposition route Tetrahedron Lett 49 2008 1049 1052
135. 4X-models of enzyme inhibitors Eur J Med Chem 2008 4200 4205
136. F. Labrie Intracrinology Mol Cell Endocrinol 78 1991 C113 C118
137. R. Hobkirk Steroid sulfation current concepts Trends Endocrinol Metab 4 1993 69 74
138. P.A. Foster, L.W.L. Woo, B.V.L. Potter, M.J. Reed, and A. Purohit The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer Endocrinology 149 2008 4035 4042
139. L. Fusi, A. Purohit, J. Brosens, L.W.L. Woo, B.V.L. Potter, and M.J. Reed Inhibition of steroid sulphatase activity in endometriotic implants by STX64 (667 COUMATE): a potential new therapy TheScientificWorldJournal 8 2008 1325 1327
140. H. Utsunomiya, K. Ito, T. Suzuki, T. Kitamura, C. Kaneko, and T. Nakata Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma Clin Cancer Res 10 2004 5850 5856 (Pubitemid 39180965)
141. A. Purohit, L. Fusi, J. Brosens, L.W.L. Woo, and B.V.L. Potter Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy Hum Reprod 23 2008 290 297 (Pubitemid 351651236)
142. J.C. Chura, H.S. Ryu, M. Simard, D. Poirier, Y. Tremblay, and D.C. Brooker Steroid-converting enzymes in human ovarian carcinomas Mol Cell Endocrinol 301 2009 51 58
143. M.J. Reed, A. Purohit, L.W.L. Woo, and B.V.L. Potter Steroid sulfatase inhibitors for the topical treatment of skin disorders Drugs Future 33 2008 597 606
144. R. Hoffmann, A. Rot, S. Niiyama, and A. Billich Steroid sulfatase in the human hair follicle concentrates in the dermal papilla J Invest Dermatol 117 2001 1342 1348 (Pubitemid 34032758)
145. M.R. Namazi Steroid sulfatase inhibitors as novel additions to the antipsoriatic armamentarium Med Sci Monit 11 2005 7 9
146. K.J. Brookes, Z. Hawi, A. Kirley, E. Barry, M. Gill, and L. Kent Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder Am J Med Genet Part 147B 2008 1531 1535
147. W. Davies, T. Humby, W. Kong, T. Otter, P.S. Burgoyne, and L.S. Wilkinson Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention Biol Psychiatry 66 2009 360 367
148. J.M. Day, A. Purohit, H.J. Tutill, P.A. Foster, L.W.L. Woo, and B.V.L. Potter The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy Ann N Y Acad Sci 1155 2009 80 87
149. P.A. Foster, S.K. Chander, M.F.C. Parsons, S.P. Newman, L.W.L. Woo, and B.V.L. Potter Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer Breast Cancer Res Treat 111 2008 129 138 (Pubitemid 352009238)
150. P.A. Foster, S.K. Chander, S.P. Newman, L.W.L. Woo, O.B. Sutcliffe, and C. Bubert A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor Clin Cancer Res 14 2008 6469 6476